Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).

Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).

British journal of haematology (2013-10-18)

Brian T Hill, Paolo Caimi, Tammy Kindwall-Keller, Becky Habecker, Matt Kalaycio

材料

产品编号

品牌

产品描述

Sigma-Aldrich

2-氟肾上腺素-9-β-D-阿拉伯呋喃糖苷, DNA synthesis and methylation inhibitor

Sigma-Aldrich

腺嘌呤9-β-D-阿拉伯呋喃糖苷, ≥99%